Researchers have found that those who lose weight using blockbuster GLP-1 drugs such as Ozempic could regain all their weight ...

"Suicidality significantly declined" among trans youth who receive hormone replacement therapy, a new study has found.

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

Patients with chronic illnesses face a significantly higher risk of complications from cosmetic botulinum toxin injections, ...

Glucagon-like peptide-1 receptor agonists (GLP-1s or GLP-1RAs) – also known as weight-loss jabs – are medicines that help ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

People who stop taking weight-loss jabs such as Wegovy regain pounds much faster than those who halt exercising and dieting, ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...

Investigation of 223 New York medical spas found unlicensed operators performing injections and laser treatments, causing ...